nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—ABCG2—Glyburide—gestational diabetes	0.155	0.634	CbGbCtD
Dasatinib—ABCB1—Glyburide—gestational diabetes	0.056	0.229	CbGbCtD
Dasatinib—CYP3A4—Glyburide—gestational diabetes	0.0335	0.137	CbGbCtD
Dasatinib—Myelosuppression—Glyburide—gestational diabetes	0.00789	0.0956	CcSEcCtD
Dasatinib—Drug eruption—Glyburide—gestational diabetes	0.00601	0.0729	CcSEcCtD
Dasatinib—STAT5B—islet of Langerhans—gestational diabetes	0.00504	0.0134	CbGeAlD
Dasatinib—MYT1—head—gestational diabetes	0.00497	0.0132	CbGeAlD
Dasatinib—STAT5B—embryo—gestational diabetes	0.00488	0.013	CbGeAlD
Dasatinib—Cholestasis—Glyburide—gestational diabetes	0.00487	0.059	CcSEcCtD
Dasatinib—Coagulopathy—Glyburide—gestational diabetes	0.00475	0.0576	CcSEcCtD
Dasatinib—TEC—vagina—gestational diabetes	0.00458	0.0122	CbGeAlD
Dasatinib—EPHB1—adipose tissue—gestational diabetes	0.00432	0.0115	CbGeAlD
Dasatinib—SIK2—adipose tissue—gestational diabetes	0.00382	0.0101	CbGeAlD
Dasatinib—TESK1—islet of Langerhans—gestational diabetes	0.00373	0.00991	CbGeAlD
Dasatinib—BMX—uterus—gestational diabetes	0.00371	0.00987	CbGeAlD
Dasatinib—BMX—adipose tissue—gestational diabetes	0.00363	0.00965	CbGeAlD
Dasatinib—SRMS—uterus—gestational diabetes	0.00355	0.00944	CbGeAlD
Dasatinib—EPHB3—embryo—gestational diabetes	0.00355	0.00943	CbGeAlD
Dasatinib—STK35—islet of Langerhans—gestational diabetes	0.00344	0.00914	CbGeAlD
Dasatinib—CSK—islet of Langerhans—gestational diabetes	0.00341	0.00908	CbGeAlD
Dasatinib—EPHB1—head—gestational diabetes	0.00332	0.00882	CbGeAlD
Dasatinib—CSK—embryo—gestational diabetes	0.0033	0.00878	CbGeAlD
Dasatinib—STAT5B—uterus—gestational diabetes	0.00329	0.00875	CbGeAlD
Dasatinib—STAT5B—adipose tissue—gestational diabetes	0.00322	0.00855	CbGeAlD
Dasatinib—RIPK2—islet of Langerhans—gestational diabetes	0.00317	0.00843	CbGeAlD
Dasatinib—SIK1—islet of Langerhans—gestational diabetes	0.00309	0.00823	CbGeAlD
Dasatinib—PKMYT1—vagina—gestational diabetes	0.00309	0.00822	CbGeAlD
Dasatinib—EPHA3—adipose tissue—gestational diabetes	0.00297	0.00791	CbGeAlD
Dasatinib—EPHA4—embryo—gestational diabetes	0.00296	0.00788	CbGeAlD
Dasatinib—SIK3—uterus—gestational diabetes	0.00296	0.00786	CbGeAlD
Dasatinib—ERBB3—embryo—gestational diabetes	0.00293	0.0078	CbGeAlD
Dasatinib—SIK2—head—gestational diabetes	0.00293	0.00779	CbGeAlD
Dasatinib—SIK3—adipose tissue—gestational diabetes	0.00289	0.00769	CbGeAlD
Dasatinib—TXK—vagina—gestational diabetes	0.00286	0.0076	CbGeAlD
Dasatinib—PKMYT1—head—gestational diabetes	0.00285	0.00759	CbGeAlD
Dasatinib—Visual disturbance—Glyburide—gestational diabetes	0.00283	0.0343	CcSEcCtD
Dasatinib—PTK6—vagina—gestational diabetes	0.00283	0.00752	CbGeAlD
Dasatinib—ZAK—uterus—gestational diabetes	0.00275	0.00731	CbGeAlD
Dasatinib—MAPK14—embryo—gestational diabetes	0.00273	0.00726	CbGeAlD
Dasatinib—EPHB2—head—gestational diabetes	0.00272	0.00724	CbGeAlD
Dasatinib—FGR—embryo—gestational diabetes	0.00272	0.00723	CbGeAlD
Dasatinib—ZAK—adipose tissue—gestational diabetes	0.00269	0.00715	CbGeAlD
Dasatinib—EPHB4—islet of Langerhans—gestational diabetes	0.00268	0.00712	CbGeAlD
Dasatinib—SRMS—head—gestational diabetes	0.00267	0.00709	CbGeAlD
Dasatinib—TXK—head—gestational diabetes	0.00264	0.00702	CbGeAlD
Dasatinib—BMPR1B—uterus—gestational diabetes	0.00263	0.00701	CbGeAlD
Dasatinib—EPHA2—islet of Langerhans—gestational diabetes	0.00263	0.00698	CbGeAlD
Dasatinib—EPHA8—head—gestational diabetes	0.00261	0.00695	CbGeAlD
Dasatinib—TNK2—uterus—gestational diabetes	0.00258	0.00687	CbGeAlD
Dasatinib—BMPR1B—adipose tissue—gestational diabetes	0.00258	0.00685	CbGeAlD
Dasatinib—JAK2—embryo—gestational diabetes	0.00257	0.00684	CbGeAlD
Dasatinib—BTK—adipose tissue—gestational diabetes	0.00256	0.00682	CbGeAlD
Dasatinib—MAP4K5—islet of Langerhans—gestational diabetes	0.00256	0.00681	CbGeAlD
Dasatinib—FYN—embryo—gestational diabetes	0.00254	0.00674	CbGeAlD
Dasatinib—TNK2—adipose tissue—gestational diabetes	0.00253	0.00672	CbGeAlD
Dasatinib—STAT5B—head—gestational diabetes	0.00247	0.00657	CbGeAlD
Dasatinib—EPHB6—islet of Langerhans—gestational diabetes	0.00245	0.00651	CbGeAlD
Dasatinib—EPHB3—uterus—gestational diabetes	0.00239	0.00636	CbGeAlD
Dasatinib—TESK1—adipose tissue—gestational diabetes	0.00238	0.00632	CbGeAlD
Dasatinib—YES1—islet of Langerhans—gestational diabetes	0.00237	0.00629	CbGeAlD
Dasatinib—STK36—adipose tissue—gestational diabetes	0.00234	0.00622	CbGeAlD
Dasatinib—Abdominal distension—Glyburide—gestational diabetes	0.00234	0.0283	CcSEcCtD
Dasatinib—LIMK2—uterus—gestational diabetes	0.00231	0.00615	CbGeAlD
Dasatinib—EPHA3—head—gestational diabetes	0.00228	0.00607	CbGeAlD
Dasatinib—SRC—islet of Langerhans—gestational diabetes	0.00228	0.00605	CbGeAlD
Dasatinib—Pancreatitis—Glyburide—gestational diabetes	0.00227	0.0276	CcSEcCtD
Dasatinib—LIMK2—adipose tissue—gestational diabetes	0.00226	0.00601	CbGeAlD
Dasatinib—PDGFRA—embryo—gestational diabetes	0.00224	0.00597	CbGeAlD
Dasatinib—ZAK—vagina—gestational diabetes	0.00223	0.00594	CbGeAlD
Dasatinib—CSK—uterus—gestational diabetes	0.00223	0.00592	CbGeAlD
Dasatinib—SIK3—head—gestational diabetes	0.00222	0.00591	CbGeAlD
Dasatinib—Pancytopenia—Glyburide—gestational diabetes	0.0022	0.0267	CcSEcCtD
Dasatinib—SRC—embryo—gestational diabetes	0.0022	0.00585	CbGeAlD
Dasatinib—HCK—uterus—gestational diabetes	0.0022	0.00584	CbGeAlD
Dasatinib—STK35—adipose tissue—gestational diabetes	0.00219	0.00583	CbGeAlD
Dasatinib—EPHA5—vagina—gestational diabetes	0.00219	0.00582	CbGeAlD
Dasatinib—CSK—adipose tissue—gestational diabetes	0.00218	0.00579	CbGeAlD
Dasatinib—HCK—adipose tissue—gestational diabetes	0.00215	0.00572	CbGeAlD
Dasatinib—ABL2—adipose tissue—gestational diabetes	0.00214	0.00568	CbGeAlD
Dasatinib—BTK—vagina—gestational diabetes	0.00213	0.00567	CbGeAlD
Dasatinib—Photosensitivity reaction—Glyburide—gestational diabetes	0.00212	0.0257	CcSEcCtD
Dasatinib—ZAK—head—gestational diabetes	0.00206	0.00549	CbGeAlD
Dasatinib—RIPK2—adipose tissue—gestational diabetes	0.00202	0.00537	CbGeAlD
Dasatinib—EPHA5—head—gestational diabetes	0.00202	0.00537	CbGeAlD
Dasatinib—SIK1—uterus—gestational diabetes	0.00202	0.00537	CbGeAlD
Dasatinib—LYN—head—gestational diabetes	0.00201	0.00534	CbGeAlD
Dasatinib—EPHA4—uterus—gestational diabetes	0.002	0.00531	CbGeAlD
Dasatinib—BMPR1B—head—gestational diabetes	0.00198	0.00526	CbGeAlD
Dasatinib—MAP3K19—head—gestational diabetes	0.00198	0.00526	CbGeAlD
Dasatinib—ERBB3—uterus—gestational diabetes	0.00198	0.00526	CbGeAlD
Dasatinib—CSF1R—embryo—gestational diabetes	0.00198	0.00526	CbGeAlD
Dasatinib—TESK1—vagina—gestational diabetes	0.00198	0.00525	CbGeAlD
Dasatinib—SIK1—adipose tissue—gestational diabetes	0.00197	0.00525	CbGeAlD
Dasatinib—MAP3K2—uterus—gestational diabetes	0.00196	0.00521	CbGeAlD
Dasatinib—EPHA4—adipose tissue—gestational diabetes	0.00195	0.00519	CbGeAlD
Dasatinib—EPHB3—vagina—gestational diabetes	0.00194	0.00517	CbGeAlD
Dasatinib—STK36—vagina—gestational diabetes	0.00194	0.00517	CbGeAlD
Dasatinib—TNK2—head—gestational diabetes	0.00194	0.00516	CbGeAlD
Dasatinib—ERBB3—adipose tissue—gestational diabetes	0.00193	0.00514	CbGeAlD
Dasatinib—MAP3K2—adipose tissue—gestational diabetes	0.00192	0.00509	CbGeAlD
Dasatinib—LIMK2—vagina—gestational diabetes	0.00188	0.005	CbGeAlD
Dasatinib—Hepatitis—Glyburide—gestational diabetes	0.00186	0.0225	CcSEcCtD
Dasatinib—MAPK14—uterus—gestational diabetes	0.00184	0.0049	CbGeAlD
Dasatinib—LCK—uterus—gestational diabetes	0.00183	0.00488	CbGeAlD
Dasatinib—TESK1—head—gestational diabetes	0.00182	0.00485	CbGeAlD
Dasatinib—STK35—vagina—gestational diabetes	0.00182	0.00485	CbGeAlD
Dasatinib—PDGFRB—islet of Langerhans—gestational diabetes	0.00181	0.00482	CbGeAlD
Dasatinib—CSK—vagina—gestational diabetes	0.00181	0.00481	CbGeAlD
Dasatinib—MAPK14—adipose tissue—gestational diabetes	0.0018	0.00479	CbGeAlD
Dasatinib—STK36—head—gestational diabetes	0.0018	0.00478	CbGeAlD
Dasatinib—EPHB3—head—gestational diabetes	0.0018	0.00478	CbGeAlD
Dasatinib—KIT—embryo—gestational diabetes	0.00179	0.00477	CbGeAlD
Dasatinib—FGR—adipose tissue—gestational diabetes	0.00179	0.00477	CbGeAlD
Dasatinib—LCK—adipose tissue—gestational diabetes	0.00179	0.00477	CbGeAlD
Dasatinib—Visual impairment—Glyburide—gestational diabetes	0.00179	0.0217	CcSEcCtD
Dasatinib—HCK—vagina—gestational diabetes	0.00179	0.00475	CbGeAlD
Dasatinib—ABL2—vagina—gestational diabetes	0.00178	0.00472	CbGeAlD
Dasatinib—PDGFRB—embryo—gestational diabetes	0.00175	0.00466	CbGeAlD
Dasatinib—EPHB4—uterus—gestational diabetes	0.00175	0.00464	CbGeAlD
Dasatinib—LIMK2—head—gestational diabetes	0.00174	0.00462	CbGeAlD
Dasatinib—Eye disorder—Glyburide—gestational diabetes	0.00174	0.021	CcSEcCtD
Dasatinib—FMO3—adipose tissue—gestational diabetes	0.00173	0.00461	CbGeAlD
Dasatinib—FYN—uterus—gestational diabetes	0.00171	0.00455	CbGeAlD
Dasatinib—EPHB4—adipose tissue—gestational diabetes	0.00171	0.00454	CbGeAlD
Dasatinib—JAK2—adipose tissue—gestational diabetes	0.0017	0.00451	CbGeAlD
Dasatinib—STK35—head—gestational diabetes	0.00168	0.00448	CbGeAlD
Dasatinib—RIPK2—vagina—gestational diabetes	0.00168	0.00447	CbGeAlD
Dasatinib—EPHA2—adipose tissue—gestational diabetes	0.00167	0.00445	CbGeAlD
Dasatinib—FYN—adipose tissue—gestational diabetes	0.00167	0.00445	CbGeAlD
Dasatinib—CSK—head—gestational diabetes	0.00167	0.00445	CbGeAlD
Dasatinib—MAP4K5—uterus—gestational diabetes	0.00167	0.00444	CbGeAlD
Dasatinib—HCK—head—gestational diabetes	0.00165	0.00439	CbGeAlD
Dasatinib—Alopecia—Glyburide—gestational diabetes	0.00164	0.0199	CcSEcCtD
Dasatinib—MAP4K5—adipose tissue—gestational diabetes	0.00163	0.00435	CbGeAlD
Dasatinib—MAP3K3—adipose tissue—gestational diabetes	0.00163	0.00435	CbGeAlD
Dasatinib—EPHA4—vagina—gestational diabetes	0.00162	0.00432	CbGeAlD
Dasatinib—Erythema—Glyburide—gestational diabetes	0.00162	0.0196	CcSEcCtD
Dasatinib—Malnutrition—Glyburide—gestational diabetes	0.00162	0.0196	CcSEcCtD
Dasatinib—ABL1—islet of Langerhans—gestational diabetes	0.00162	0.0043	CbGeAlD
Dasatinib—ABL1—embryo—gestational diabetes	0.00156	0.00415	CbGeAlD
Dasatinib—EPHB6—adipose tissue—gestational diabetes	0.00156	0.00415	CbGeAlD
Dasatinib—RIPK2—head—gestational diabetes	0.00155	0.00413	CbGeAlD
Dasatinib—YES1—uterus—gestational diabetes	0.00154	0.0041	CbGeAlD
Dasatinib—Vision blurred—Glyburide—gestational diabetes	0.00152	0.0185	CcSEcCtD
Dasatinib—SIK1—head—gestational diabetes	0.00151	0.00403	CbGeAlD
Dasatinib—Tremor—Glyburide—gestational diabetes	0.00151	0.0184	CcSEcCtD
Dasatinib—PDGFRA—uterus—gestational diabetes	0.00151	0.00403	CbGeAlD
Dasatinib—YES1—adipose tissue—gestational diabetes	0.00151	0.00401	CbGeAlD
Dasatinib—EPHA4—head—gestational diabetes	0.0015	0.00399	CbGeAlD
Dasatinib—MAPK14—vagina—gestational diabetes	0.0015	0.00398	CbGeAlD
Dasatinib—Anaemia—Glyburide—gestational diabetes	0.00149	0.0181	CcSEcCtD
Dasatinib—FGR—vagina—gestational diabetes	0.00149	0.00397	CbGeAlD
Dasatinib—LCK—vagina—gestational diabetes	0.00149	0.00397	CbGeAlD
Dasatinib—ERBB3—head—gestational diabetes	0.00148	0.00395	CbGeAlD
Dasatinib—PDGFRA—adipose tissue—gestational diabetes	0.00148	0.00394	CbGeAlD
Dasatinib—MAP3K2—head—gestational diabetes	0.00147	0.00391	CbGeAlD
Dasatinib—SRC—adipose tissue—gestational diabetes	0.00145	0.00386	CbGeAlD
Dasatinib—FMO3—vagina—gestational diabetes	0.00144	0.00383	CbGeAlD
Dasatinib—EPHB4—vagina—gestational diabetes	0.00142	0.00377	CbGeAlD
Dasatinib—JAK2—vagina—gestational diabetes	0.00141	0.00375	CbGeAlD
Dasatinib—Convulsion—Glyburide—gestational diabetes	0.0014	0.017	CcSEcCtD
Dasatinib—EPHA2—vagina—gestational diabetes	0.00139	0.0037	CbGeAlD
Dasatinib—FYN—vagina—gestational diabetes	0.00139	0.0037	CbGeAlD
Dasatinib—MAPK14—head—gestational diabetes	0.00138	0.00368	CbGeAlD
Dasatinib—FGR—head—gestational diabetes	0.00138	0.00366	CbGeAlD
Dasatinib—Arthralgia—Glyburide—gestational diabetes	0.00138	0.0167	CcSEcCtD
Dasatinib—Myalgia—Glyburide—gestational diabetes	0.00138	0.0167	CcSEcCtD
Dasatinib—MAP4K5—vagina—gestational diabetes	0.00136	0.00361	CbGeAlD
Dasatinib—MAP3K3—vagina—gestational diabetes	0.00136	0.00361	CbGeAlD
Dasatinib—MAP2K5—adipose tissue—gestational diabetes	0.00134	0.00355	CbGeAlD
Dasatinib—CSF1R—uterus—gestational diabetes	0.00133	0.00354	CbGeAlD
Dasatinib—Confusional state—Glyburide—gestational diabetes	0.00133	0.0161	CcSEcCtD
Dasatinib—FMO3—head—gestational diabetes	0.00133	0.00354	CbGeAlD
Dasatinib—Oedema—Glyburide—gestational diabetes	0.00132	0.016	CcSEcCtD
Dasatinib—CSF1R—adipose tissue—gestational diabetes	0.0013	0.00347	CbGeAlD
Dasatinib—JAK2—head—gestational diabetes	0.0013	0.00346	CbGeAlD
Dasatinib—EPHB6—vagina—gestational diabetes	0.0013	0.00345	CbGeAlD
Dasatinib—Shock—Glyburide—gestational diabetes	0.0013	0.0157	CcSEcCtD
Dasatinib—Nervous system disorder—Glyburide—gestational diabetes	0.00129	0.0157	CcSEcCtD
Dasatinib—Thrombocytopenia—Glyburide—gestational diabetes	0.00129	0.0157	CcSEcCtD
Dasatinib—EPHA2—head—gestational diabetes	0.00129	0.00342	CbGeAlD
Dasatinib—FYN—head—gestational diabetes	0.00128	0.00341	CbGeAlD
Dasatinib—Hyperhidrosis—Glyburide—gestational diabetes	0.00128	0.0155	CcSEcCtD
Dasatinib—Anorexia—Glyburide—gestational diabetes	0.00126	0.0152	CcSEcCtD
Dasatinib—MAP3K3—head—gestational diabetes	0.00125	0.00334	CbGeAlD
Dasatinib—MAP4K5—head—gestational diabetes	0.00125	0.00334	CbGeAlD
Dasatinib—YES1—vagina—gestational diabetes	0.00125	0.00334	CbGeAlD
Dasatinib—Hypotension—Glyburide—gestational diabetes	0.00123	0.0149	CcSEcCtD
Dasatinib—PDGFRA—vagina—gestational diabetes	0.00123	0.00327	CbGeAlD
Dasatinib—KIT—uterus—gestational diabetes	0.00121	0.00322	CbGeAlD
Dasatinib—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.0012	0.0146	CcSEcCtD
Dasatinib—EPHB6—head—gestational diabetes	0.0012	0.00319	CbGeAlD
Dasatinib—KIT—adipose tissue—gestational diabetes	0.00118	0.00315	CbGeAlD
Dasatinib—PDGFRB—uterus—gestational diabetes	0.00118	0.00314	CbGeAlD
Dasatinib—Dyspnoea—Glyburide—gestational diabetes	0.00118	0.0143	CcSEcCtD
Dasatinib—Dyspepsia—Glyburide—gestational diabetes	0.00116	0.0141	CcSEcCtD
Dasatinib—YES1—head—gestational diabetes	0.00116	0.00308	CbGeAlD
Dasatinib—PDGFRB—adipose tissue—gestational diabetes	0.00116	0.00307	CbGeAlD
Dasatinib—Decreased appetite—Glyburide—gestational diabetes	0.00115	0.0139	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Glyburide—gestational diabetes	0.00114	0.0138	CcSEcCtD
Dasatinib—PDGFRA—head—gestational diabetes	0.00114	0.00302	CbGeAlD
Dasatinib—SRC—head—gestational diabetes	0.00111	0.00296	CbGeAlD
Dasatinib—MAP2K5—vagina—gestational diabetes	0.00111	0.00295	CbGeAlD
Dasatinib—Feeling abnormal—Glyburide—gestational diabetes	0.00109	0.0132	CcSEcCtD
Dasatinib—CSF1R—vagina—gestational diabetes	0.00108	0.00288	CbGeAlD
Dasatinib—Gastrointestinal pain—Glyburide—gestational diabetes	0.00108	0.0131	CcSEcCtD
Dasatinib—ABL1—uterus—gestational diabetes	0.00105	0.0028	CbGeAlD
Dasatinib—Urticaria—Glyburide—gestational diabetes	0.00105	0.0127	CcSEcCtD
Dasatinib—Abdominal pain—Glyburide—gestational diabetes	0.00104	0.0126	CcSEcCtD
Dasatinib—ABL1—adipose tissue—gestational diabetes	0.00103	0.00274	CbGeAlD
Dasatinib—MAP2K5—head—gestational diabetes	0.00103	0.00273	CbGeAlD
Dasatinib—CSF1R—head—gestational diabetes	0.001	0.00266	CbGeAlD
Dasatinib—KIT—vagina—gestational diabetes	0.000984	0.00262	CbGeAlD
Dasatinib—Hypersensitivity—Glyburide—gestational diabetes	0.000972	0.0118	CcSEcCtD
Dasatinib—PDGFRB—vagina—gestational diabetes	0.000961	0.00256	CbGeAlD
Dasatinib—Asthenia—Glyburide—gestational diabetes	0.000946	0.0115	CcSEcCtD
Dasatinib—CYP3A5—islet of Langerhans—gestational diabetes	0.000945	0.00251	CbGeAlD
Dasatinib—Pruritus—Glyburide—gestational diabetes	0.000933	0.0113	CcSEcCtD
Dasatinib—KIT—head—gestational diabetes	0.000909	0.00242	CbGeAlD
Dasatinib—Diarrhoea—Glyburide—gestational diabetes	0.000903	0.0109	CcSEcCtD
Dasatinib—CYP1B1—uterus—gestational diabetes	0.000892	0.00237	CbGeAlD
Dasatinib—PDGFRB—head—gestational diabetes	0.000887	0.00236	CbGeAlD
Dasatinib—CYP1B1—adipose tissue—gestational diabetes	0.000872	0.00232	CbGeAlD
Dasatinib—ABL1—vagina—gestational diabetes	0.000856	0.00228	CbGeAlD
Dasatinib—Vomiting—Glyburide—gestational diabetes	0.000839	0.0102	CcSEcCtD
Dasatinib—Rash—Glyburide—gestational diabetes	0.000832	0.0101	CcSEcCtD
Dasatinib—Dermatitis—Glyburide—gestational diabetes	0.000831	0.0101	CcSEcCtD
Dasatinib—Headache—Glyburide—gestational diabetes	0.000826	0.01	CcSEcCtD
Dasatinib—ABL1—head—gestational diabetes	0.000791	0.0021	CbGeAlD
Dasatinib—Nausea—Glyburide—gestational diabetes	0.000784	0.0095	CcSEcCtD
Dasatinib—CYP1B1—head—gestational diabetes	0.00067	0.00178	CbGeAlD
Dasatinib—ABCG2—uterus—gestational diabetes	0.000664	0.00177	CbGeAlD
Dasatinib—ABCG2—adipose tissue—gestational diabetes	0.00065	0.00173	CbGeAlD
Dasatinib—CYP1A1—uterus—gestational diabetes	0.000631	0.00168	CbGeAlD
Dasatinib—CYP1A1—adipose tissue—gestational diabetes	0.000617	0.00164	CbGeAlD
Dasatinib—CYP3A5—adipose tissue—gestational diabetes	0.000603	0.0016	CbGeAlD
Dasatinib—ABCG2—vagina—gestational diabetes	0.00054	0.00144	CbGeAlD
Dasatinib—CYP1A1—vagina—gestational diabetes	0.000513	0.00136	CbGeAlD
Dasatinib—ABCB1—islet of Langerhans—gestational diabetes	0.000502	0.00134	CbGeAlD
Dasatinib—CYP3A5—vagina—gestational diabetes	0.000501	0.00133	CbGeAlD
Dasatinib—ABCB1—embryo—gestational diabetes	0.000486	0.00129	CbGeAlD
Dasatinib—CYP1A1—head—gestational diabetes	0.000474	0.00126	CbGeAlD
Dasatinib—ABCB1—uterus—gestational diabetes	0.000328	0.000871	CbGeAlD
Dasatinib—ABCB1—adipose tissue—gestational diabetes	0.00032	0.000852	CbGeAlD
Dasatinib—ABCB1—vagina—gestational diabetes	0.000266	0.000708	CbGeAlD
Dasatinib—ABCB1—head—gestational diabetes	0.000246	0.000654	CbGeAlD
Dasatinib—PDGFRA—Immune System—MBL2—gestational diabetes	0.000135	0.000453	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—RBP4—gestational diabetes	0.000134	0.000452	CbGpPWpGaD
Dasatinib—EPHA8—Developmental Biology—TNF—gestational diabetes	0.000133	0.00045	CbGpPWpGaD
Dasatinib—LCK—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000133	0.000448	CbGpPWpGaD
Dasatinib—SRC—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000133	0.000448	CbGpPWpGaD
Dasatinib—KIT—Disease—RBP4—gestational diabetes	0.000132	0.000446	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—GLS2—gestational diabetes	0.000132	0.000445	CbGpPWpGaD
Dasatinib—EPHB4—Developmental Biology—TNF—gestational diabetes	0.000132	0.000444	CbGpPWpGaD
Dasatinib—LIMK2—Developmental Biology—TNF—gestational diabetes	0.000132	0.000444	CbGpPWpGaD
Dasatinib—EPHA4—Developmental Biology—TNF—gestational diabetes	0.000132	0.000444	CbGpPWpGaD
Dasatinib—SRC—Signaling by EGFR—FGF2—gestational diabetes	0.000132	0.000444	CbGpPWpGaD
Dasatinib—HCK—Innate Immune System—FGF2—gestational diabetes	0.000131	0.000441	CbGpPWpGaD
Dasatinib—SRC—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000131	0.00044	CbGpPWpGaD
Dasatinib—SRC—Signaling by PDGF—FGF2—gestational diabetes	0.00013	0.000438	CbGpPWpGaD
Dasatinib—MAPK14—Regulation of toll-like receptor signaling pathway—TNF—gestational diabetes	0.000128	0.000432	CbGpPWpGaD
Dasatinib—EPHB2—Developmental Biology—TNF—gestational diabetes	0.000128	0.00043	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling by NGF—FGF2—gestational diabetes	0.000127	0.000429	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—MTNR1B—gestational diabetes	0.000126	0.000424	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—MTNR1B—gestational diabetes	0.000126	0.000424	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—RBP4—gestational diabetes	0.000125	0.000422	CbGpPWpGaD
Dasatinib—SRC—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000125	0.000421	CbGpPWpGaD
Dasatinib—EPHB6—Developmental Biology—TNF—gestational diabetes	0.000124	0.000418	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—ADIPOQ—gestational diabetes	0.000124	0.000417	CbGpPWpGaD
Dasatinib—RIPK2—Innate Immune System—FGF2—gestational diabetes	0.000123	0.000415	CbGpPWpGaD
Dasatinib—FYN—Signaling by NGF—FGF2—gestational diabetes	0.000123	0.000414	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—RBP4—gestational diabetes	0.000123	0.000413	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—MTNR1B—gestational diabetes	0.000121	0.000409	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—MBL2—gestational diabetes	0.000121	0.000408	CbGpPWpGaD
Dasatinib—CYP1A2—Biological oxidations—CYP19A1—gestational diabetes	0.000121	0.000407	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—LEPR—gestational diabetes	0.00012	0.000405	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—GLS2—gestational diabetes	0.00012	0.000405	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—LEP—gestational diabetes	0.00012	0.000404	CbGpPWpGaD
Dasatinib—CYP1A2—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000119	0.000401	CbGpPWpGaD
Dasatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000119	0.000401	CbGpPWpGaD
Dasatinib—PDGFRB—MAPK Signaling Pathway—TNF—gestational diabetes	0.000119	0.0004	CbGpPWpGaD
Dasatinib—KIT—Disease—NAMPT—gestational diabetes	0.000119	0.0004	CbGpPWpGaD
Dasatinib—LYN—Immune System—MBL2—gestational diabetes	0.000119	0.0004	CbGpPWpGaD
Dasatinib—RIPK2—Adaptive Immune System—FGF2—gestational diabetes	0.000118	0.000399	CbGpPWpGaD
Dasatinib—MAPK14—Signaling by NGF—FGF2—gestational diabetes	0.000118	0.000398	CbGpPWpGaD
Dasatinib—FGR—Innate Immune System—FGF2—gestational diabetes	0.000118	0.000398	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—RBP4—gestational diabetes	0.000118	0.000398	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000118	0.000398	CbGpPWpGaD
Dasatinib—ABL1—Immune System—MBL2—gestational diabetes	0.000118	0.000398	CbGpPWpGaD
Dasatinib—KIT—Disease—GCK—gestational diabetes	0.000118	0.000397	CbGpPWpGaD
Dasatinib—SRC—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000118	0.000396	CbGpPWpGaD
Dasatinib—FMO3—Metabolism—CYP19A1—gestational diabetes	0.000117	0.000395	CbGpPWpGaD
Dasatinib—FYN—Immune System—MBL2—gestational diabetes	0.000117	0.000394	CbGpPWpGaD
Dasatinib—JAK2—Signaling by NGF—FGF2—gestational diabetes	0.000117	0.000393	CbGpPWpGaD
Dasatinib—BLK—Adaptive Immune System—FGF2—gestational diabetes	0.000114	0.000384	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—LEPR—gestational diabetes	0.000114	0.000384	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—RBP4—gestational diabetes	0.000113	0.00038	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—MBL2—gestational diabetes	0.000113	0.000379	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—NAMPT—gestational diabetes	0.000112	0.000378	CbGpPWpGaD
Dasatinib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	0.000112	0.000378	CbGpPWpGaD
Dasatinib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	0.000112	0.000378	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—GCK—gestational diabetes	0.000112	0.000376	CbGpPWpGaD
Dasatinib—JAK2—Immune System—MBL2—gestational diabetes	0.000111	0.000374	CbGpPWpGaD
Dasatinib—MAPK14—MAPK Signaling Pathway—TNF—gestational diabetes	0.00011	0.000371	CbGpPWpGaD
Dasatinib—FYN—Disease—RBP4—gestational diabetes	0.000109	0.000366	CbGpPWpGaD
Dasatinib—ERBB3—Innate Immune System—FGF2—gestational diabetes	0.000109	0.000366	CbGpPWpGaD
Dasatinib—YES1—Developmental Biology—FGF2—gestational diabetes	0.000108	0.000364	CbGpPWpGaD
Dasatinib—EPHA2—Developmental Biology—TNF—gestational diabetes	0.000108	0.000362	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—MTNR1B—gestational diabetes	0.000106	0.000359	CbGpPWpGaD
Dasatinib—LYN—Developmental Biology—LEP—gestational diabetes	0.000106	0.000357	CbGpPWpGaD
Dasatinib—ABL1—Developmental Biology—LEP—gestational diabetes	0.000106	0.000356	CbGpPWpGaD
Dasatinib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000104	0.000352	CbGpPWpGaD
Dasatinib—FYN—Developmental Biology—LEP—gestational diabetes	0.000104	0.000352	CbGpPWpGaD
Dasatinib—ERBB3—Adaptive Immune System—FGF2—gestational diabetes	0.000104	0.000352	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—RBP4—gestational diabetes	0.000104	0.00035	CbGpPWpGaD
Dasatinib—JAK2—Disease—RBP4—gestational diabetes	0.000103	0.000348	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—LEPR—gestational diabetes	0.000103	0.000346	CbGpPWpGaD
Dasatinib—LCK—Signaling by NGF—FGF2—gestational diabetes	0.000102	0.000344	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—NAMPT—gestational diabetes	0.000101	0.000341	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—GCK—gestational diabetes	0.000101	0.000339	CbGpPWpGaD
Dasatinib—MAPK14—Developmental Biology—LEP—gestational diabetes	0.000101	0.000339	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—LEPR—gestational diabetes	0.0001	0.000338	CbGpPWpGaD
Dasatinib—MAPK14—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	9.95e-05	0.000335	CbGpPWpGaD
Dasatinib—CSK—Immune System—FGF2—gestational diabetes	9.93e-05	0.000335	CbGpPWpGaD
Dasatinib—JAK2—Developmental Biology—LEP—gestational diabetes	9.93e-05	0.000334	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—LEPR—gestational diabetes	9.89e-05	0.000333	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—GGCT—gestational diabetes	9.86e-05	0.000332	CbGpPWpGaD
Dasatinib—FYN—Disease—NAMPT—gestational diabetes	9.76e-05	0.000329	CbGpPWpGaD
Dasatinib—LCK—Immune System—MBL2—gestational diabetes	9.73e-05	0.000328	CbGpPWpGaD
Dasatinib—FYN—Disease—GCK—gestational diabetes	9.69e-05	0.000327	CbGpPWpGaD
Dasatinib—STAT5B—Immune System—FGF2—gestational diabetes	9.62e-05	0.000324	CbGpPWpGaD
Dasatinib—YES1—Innate Immune System—FGF2—gestational diabetes	9.54e-05	0.000321	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—LEPR—gestational diabetes	9.52e-05	0.000321	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—MTNR1B—gestational diabetes	9.51e-05	0.00032	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—LEPR—gestational diabetes	9.4e-05	0.000317	CbGpPWpGaD
Dasatinib—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	9.33e-05	0.000314	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—GGCT—gestational diabetes	9.31e-05	0.000314	CbGpPWpGaD
Dasatinib—JAK2—Disease—NAMPT—gestational diabetes	9.27e-05	0.000312	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—RBP4—gestational diabetes	9.27e-05	0.000312	CbGpPWpGaD
Dasatinib—JAK2—Disease—GCK—gestational diabetes	9.22e-05	0.00031	CbGpPWpGaD
Dasatinib—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	9.2e-05	0.00031	CbGpPWpGaD
Dasatinib—CSK—Disease—FGF2—gestational diabetes	9.17e-05	0.000309	CbGpPWpGaD
Dasatinib—YES1—Adaptive Immune System—FGF2—gestational diabetes	9.16e-05	0.000309	CbGpPWpGaD
Dasatinib—ABCB1—Allograft Rejection—TNF—gestational diabetes	9.13e-05	0.000307	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—FGF2—gestational diabetes	9.12e-05	0.000307	CbGpPWpGaD
Dasatinib—LCK—Disease—RBP4—gestational diabetes	9.06e-05	0.000305	CbGpPWpGaD
Dasatinib—SRC—Signaling by NGF—FGF2—gestational diabetes	9.05e-05	0.000305	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—MTNR1B—gestational diabetes	9e-05	0.000303	CbGpPWpGaD
Dasatinib—STAT5B—Disease—FGF2—gestational diabetes	8.88e-05	0.000299	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—RBP4—gestational diabetes	8.77e-05	0.000295	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—GLS2—gestational diabetes	8.62e-05	0.00029	CbGpPWpGaD
Dasatinib—SRC—Immune System—MBL2—gestational diabetes	8.61e-05	0.00029	CbGpPWpGaD
Dasatinib—MAP3K3—Immune System—FGF2—gestational diabetes	8.54e-05	0.000288	CbGpPWpGaD
Dasatinib—KIT—Innate Immune System—FGF2—gestational diabetes	8.52e-05	0.000287	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—LEP—gestational diabetes	8.46e-05	0.000285	CbGpPWpGaD
Dasatinib—BTK—Immune System—FGF2—gestational diabetes	8.31e-05	0.00028	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—LEPR—gestational diabetes	8.23e-05	0.000277	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—LEP—gestational diabetes	8.19e-05	0.000276	CbGpPWpGaD
Dasatinib—KIT—Adaptive Immune System—FGF2—gestational diabetes	8.18e-05	0.000276	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—GLS2—gestational diabetes	8.14e-05	0.000274	CbGpPWpGaD
Dasatinib—LCK—Disease—NAMPT—gestational diabetes	8.12e-05	0.000274	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—MTNR1B—gestational diabetes	8.11e-05	0.000273	CbGpPWpGaD
Dasatinib—LCK—Disease—GCK—gestational diabetes	8.07e-05	0.000272	CbGpPWpGaD
Dasatinib—PDGFRA—Innate Immune System—FGF2—gestational diabetes	8.07e-05	0.000272	CbGpPWpGaD
Dasatinib—LYN—Developmental Biology—FGF2—gestational diabetes	8.06e-05	0.000271	CbGpPWpGaD
Dasatinib—ABL1—Developmental Biology—FGF2—gestational diabetes	8.02e-05	0.00027	CbGpPWpGaD
Dasatinib—SRC—Disease—RBP4—gestational diabetes	8.02e-05	0.00027	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—MTNR1B—gestational diabetes	7.94e-05	0.000267	CbGpPWpGaD
Dasatinib—FYN—Developmental Biology—FGF2—gestational diabetes	7.93e-05	0.000267	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—RBP4—gestational diabetes	7.9e-05	0.000266	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—MTNR1B—gestational diabetes	7.82e-05	0.000263	CbGpPWpGaD
Dasatinib—PDGFRA—Adaptive Immune System—FGF2—gestational diabetes	7.75e-05	0.000261	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—RBP4—gestational diabetes	7.74e-05	0.000261	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—LEP—gestational diabetes	7.7e-05	0.000259	CbGpPWpGaD
Dasatinib—MAPK14—Developmental Biology—FGF2—gestational diabetes	7.64e-05	0.000257	CbGpPWpGaD
Dasatinib—HCK—Immune System—FGF2—gestational diabetes	7.62e-05	0.000257	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—RBP4—gestational diabetes	7.62e-05	0.000257	CbGpPWpGaD
Dasatinib—SRC—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	7.61e-05	0.000256	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—GCK—gestational diabetes	7.56e-05	0.000255	CbGpPWpGaD
Dasatinib—JAK2—Developmental Biology—FGF2—gestational diabetes	7.54e-05	0.000254	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—MTNR1B—gestational diabetes	7.53e-05	0.000254	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—GGCT—gestational diabetes	7.44e-05	0.000251	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—MTNR1B—gestational diabetes	7.43e-05	0.00025	CbGpPWpGaD
Dasatinib—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	7.4e-05	0.000249	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—RBP4—gestational diabetes	7.33e-05	0.000247	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—LEPR—gestational diabetes	7.29e-05	0.000246	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	7.28e-05	0.000245	CbGpPWpGaD
Dasatinib—PDGFRB—Innate Immune System—FGF2—gestational diabetes	7.27e-05	0.000245	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—NAMPT—gestational diabetes	7.24e-05	0.000244	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—RBP4—gestational diabetes	7.24e-05	0.000244	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—GCK—gestational diabetes	7.2e-05	0.000242	CbGpPWpGaD
Dasatinib—SRC—Disease—NAMPT—gestational diabetes	7.19e-05	0.000242	CbGpPWpGaD
Dasatinib—RIPK2—Immune System—FGF2—gestational diabetes	7.18e-05	0.000242	CbGpPWpGaD
Dasatinib—MAPK14—Gene Expression—AR—gestational diabetes	7.15e-05	0.000241	CbGpPWpGaD
Dasatinib—SRC—Disease—GCK—gestational diabetes	7.15e-05	0.000241	CbGpPWpGaD
Dasatinib—LYN—Innate Immune System—FGF2—gestational diabetes	7.12e-05	0.00024	CbGpPWpGaD
Dasatinib—ABL1—Innate Immune System—FGF2—gestational diabetes	7.08e-05	0.000239	CbGpPWpGaD
Dasatinib—HCK—Disease—FGF2—gestational diabetes	7.04e-05	0.000237	CbGpPWpGaD
Dasatinib—FYN—Innate Immune System—FGF2—gestational diabetes	7.01e-05	0.000236	CbGpPWpGaD
Dasatinib—PDGFRB—Adaptive Immune System—FGF2—gestational diabetes	6.98e-05	0.000235	CbGpPWpGaD
Dasatinib—BLK—Immune System—FGF2—gestational diabetes	6.91e-05	0.000233	CbGpPWpGaD
Dasatinib—FGR—Immune System—FGF2—gestational diabetes	6.89e-05	0.000232	CbGpPWpGaD
Dasatinib—LYN—Adaptive Immune System—FGF2—gestational diabetes	6.83e-05	0.00023	CbGpPWpGaD
Dasatinib—MAPK14—Innate Immune System—FGF2—gestational diabetes	6.75e-05	0.000227	CbGpPWpGaD
Dasatinib—FYN—Adaptive Immune System—FGF2—gestational diabetes	6.73e-05	0.000227	CbGpPWpGaD
Dasatinib—JAK2—Innate Immune System—FGF2—gestational diabetes	6.66e-05	0.000224	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—NAMPT—gestational diabetes	6.59e-05	0.000222	CbGpPWpGaD
Dasatinib—YES1—Developmental Biology—TNF—gestational diabetes	6.58e-05	0.000222	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—GCK—gestational diabetes	6.55e-05	0.000221	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—MTNR1B—gestational diabetes	6.51e-05	0.000219	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—GLS2—gestational diabetes	6.5e-05	0.000219	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—FGF2—gestational diabetes	6.42e-05	0.000216	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—RBP4—gestational diabetes	6.34e-05	0.000214	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—FGF2—gestational diabetes	6.33e-05	0.000213	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—FGF2—gestational diabetes	6.22e-05	0.00021	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—LEP—gestational diabetes	6.11e-05	0.000206	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GGCT—gestational diabetes	5.94e-05	0.0002	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—FGF2—gestational diabetes	5.85e-05	0.000197	CbGpPWpGaD
Dasatinib—ERBB3—Disease—FGF2—gestational diabetes	5.85e-05	0.000197	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—FGF2—gestational diabetes	5.83e-05	0.000196	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—MTNR1B—gestational diabetes	5.76e-05	0.000194	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—RBP4—gestational diabetes	5.61e-05	0.000189	CbGpPWpGaD
Dasatinib—LCK—Adaptive Immune System—FGF2—gestational diabetes	5.6e-05	0.000189	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—LEP—gestational diabetes	5.59e-05	0.000188	CbGpPWpGaD
Dasatinib—YES1—Immune System—FGF2—gestational diabetes	5.56e-05	0.000187	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—LEP—gestational diabetes	5.39e-05	0.000182	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—CYP19A1—gestational diabetes	5.26e-05	0.000177	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GLS2—gestational diabetes	5.19e-05	0.000175	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—FGF2—gestational diabetes	5.16e-05	0.000174	CbGpPWpGaD
Dasatinib—KIT—Immune System—FGF2—gestational diabetes	4.96e-05	0.000167	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—FGF2—gestational diabetes	4.96e-05	0.000167	CbGpPWpGaD
Dasatinib—LYN—Developmental Biology—TNF—gestational diabetes	4.91e-05	0.000165	CbGpPWpGaD
Dasatinib—ABL1—Developmental Biology—TNF—gestational diabetes	4.88e-05	0.000165	CbGpPWpGaD
Dasatinib—FYN—Developmental Biology—TNF—gestational diabetes	4.83e-05	0.000163	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—CYP19A1—gestational diabetes	4.79e-05	0.000161	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—LEP—gestational diabetes	4.73e-05	0.000159	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—NAMPT—gestational diabetes	4.72e-05	0.000159	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—FGF2—gestational diabetes	4.7e-05	0.000158	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—GCK—gestational diabetes	4.69e-05	0.000158	CbGpPWpGaD
Dasatinib—MAPK14—Developmental Biology—TNF—gestational diabetes	4.65e-05	0.000157	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—FGF2—gestational diabetes	4.64e-05	0.000156	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	4.64e-05	0.000156	CbGpPWpGaD
Dasatinib—JAK2—Developmental Biology—TNF—gestational diabetes	4.59e-05	0.000155	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GGCT—gestational diabetes	4.58e-05	0.000154	CbGpPWpGaD
Dasatinib—KIT—Disease—FGF2—gestational diabetes	4.58e-05	0.000154	CbGpPWpGaD
Dasatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	4.5e-05	0.000152	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—NAMPT—gestational diabetes	4.46e-05	0.00015	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—GCK—gestational diabetes	4.43e-05	0.000149	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—FGF2—gestational diabetes	4.34e-05	0.000146	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—FGF2—gestational diabetes	4.25e-05	0.000143	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—FGF2—gestational diabetes	4.23e-05	0.000143	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—LEP—gestational diabetes	4.22e-05	0.000142	CbGpPWpGaD
Dasatinib—LYN—Immune System—FGF2—gestational diabetes	4.14e-05	0.00014	CbGpPWpGaD
Dasatinib—ABL1—Immune System—FGF2—gestational diabetes	4.13e-05	0.000139	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—FGF2—gestational diabetes	4.09e-05	0.000138	CbGpPWpGaD
Dasatinib—FYN—Immune System—FGF2—gestational diabetes	4.08e-05	0.000137	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GLS2—gestational diabetes	4.01e-05	0.000135	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—LEP—gestational diabetes	4e-05	0.000135	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—FGF2—gestational diabetes	3.93e-05	0.000132	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—FGF2—gestational diabetes	3.91e-05	0.000132	CbGpPWpGaD
Dasatinib—JAK2—Immune System—FGF2—gestational diabetes	3.88e-05	0.000131	CbGpPWpGaD
Dasatinib—FYN—Disease—FGF2—gestational diabetes	3.77e-05	0.000127	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—LEP—gestational diabetes	3.6e-05	0.000121	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—FGF2—gestational diabetes	3.59e-05	0.000121	CbGpPWpGaD
Dasatinib—JAK2—Disease—FGF2—gestational diabetes	3.58e-05	0.000121	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—NAMPT—gestational diabetes	3.56e-05	0.00012	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—TNF—gestational diabetes	3.56e-05	0.00012	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—GCK—gestational diabetes	3.54e-05	0.000119	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—LEP—gestational diabetes	3.53e-05	0.000119	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—LEP—gestational diabetes	3.47e-05	0.000117	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—CYP19A1—gestational diabetes	3.43e-05	0.000116	CbGpPWpGaD
Dasatinib—LCK—Immune System—FGF2—gestational diabetes	3.4e-05	0.000114	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—LEP—gestational diabetes	3.34e-05	0.000113	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—LEP—gestational diabetes	3.3e-05	0.000111	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—CYP19A1—gestational diabetes	3.24e-05	0.000109	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—FGF2—gestational diabetes	3.21e-05	0.000108	CbGpPWpGaD
Dasatinib—LCK—Disease—FGF2—gestational diabetes	3.14e-05	0.000106	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—FGF2—gestational diabetes	3.04e-05	0.000102	CbGpPWpGaD
Dasatinib—SRC—Immune System—FGF2—gestational diabetes	3.01e-05	0.000101	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—LEP—gestational diabetes	2.89e-05	9.74e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—NAMPT—gestational diabetes	2.84e-05	9.58e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GCK—gestational diabetes	2.83e-05	9.52e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—FGF2—gestational diabetes	2.78e-05	9.35e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—FGF2—gestational diabetes	2.74e-05	9.22e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—FGF2—gestational diabetes	2.68e-05	9.03e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—FGF2—gestational diabetes	2.64e-05	8.89e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—CYP19A1—gestational diabetes	2.59e-05	8.72e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—LEP—gestational diabetes	2.56e-05	8.62e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—FGF2—gestational diabetes	2.54e-05	8.56e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—FGF2—gestational diabetes	2.51e-05	8.45e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—FGF2—gestational diabetes	2.2e-05	7.4e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—NAMPT—gestational diabetes	2.2e-05	7.39e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GCK—gestational diabetes	2.18e-05	7.35e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CYP19A1—gestational diabetes	2.07e-05	6.96e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—FGF2—gestational diabetes	1.94e-05	6.55e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CYP19A1—gestational diabetes	1.59e-05	5.37e-05	CbGpPWpGaD
